Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

Clinicopathological correlation of endocan expression and survival in epithelial ovarian cancer.

El Behery MM, Seksaka MA, Ibrahiem MA, Saleh HS, El Alfy Y.

Arch Gynecol Obstet. 2013 Dec;288(6):1371-6. doi: 10.1007/s00404-013-2863-3. Epub 2013 May 25.

PMID:
23708323
2.

Endocan-expressing microvessel density as a prognostic factor for survival in human gastric cancer.

Chang Y, Niu W, Lian PL, Wang XQ, Meng ZX, Liu Y, Zhao R.

World J Gastroenterol. 2016 Jun 21;22(23):5422-9. doi: 10.3748/wjg.v22.i23.5422.

3.

Endocan expression correlated with poor survival in human hepatocellular carcinoma.

Huang GW, Tao YM, Ding X.

Dig Dis Sci. 2009 Feb;54(2):389-94. doi: 10.1007/s10620-008-0346-3. Epub 2008 Jul 1.

PMID:
18592377
4.
5.

Prognostic significance of tumor angiogenesis in epithelial ovarian cancer.

Obermair A, Wasicky R, Kaider A, Preyer O, Lösch A, Leodolter S, Kölbl H.

Cancer Lett. 1999 Apr 26;138(1-2):175-82.

PMID:
10378790
6.

[Prognostic value of microvessel density and angiogenesis-related molecules in epithelial ovarian cancer].

Tan XJ, Lang JH, Lou WZ, Shen K, Xu XY.

Zhonghua Zhong Liu Za Zhi. 2008 Apr;30(4):274-8. Chinese.

PMID:
18788631
7.

Expression and distribution of endocan in human tissues.

Zhang SM, Zuo L, Zhou Q, Gui SY, Shi R, Wu Q, Wei W, Wang Y.

Biotech Histochem. 2012 Apr;87(3):172-8. doi: 10.3109/10520295.2011.577754. Epub 2011 Apr 28.

PMID:
21526908
8.

Expression of hypoxia-inducible factor 1alpha gene affects the outcome in patients with ovarian cancer.

Shimogai R, Kigawa J, Itamochi H, Iba T, Kanamori Y, Oishi T, Shimada M, Sato S, Kawaguchi W, Sato S, Terakawa N.

Int J Gynecol Cancer. 2008 May-Jun;18(3):499-505. doi: 10.1111/j.1525-1438.2007.01055.x.

PMID:
18476949
9.

Prognostic significance of intratumoral vascular endothelial growth factor as a marker of tumour angiogenesis in epithelial ovarian cancer.

Siddiqui GK, Elmasry K, Wong Te Fong AC, Perrett C, Morris R, Crow JC, Maclean AB.

Eur J Gynaecol Oncol. 2010;31(2):156-9.

PMID:
20527230
10.

Endocan expression and relationship with survival in human non-small cell lung cancer.

Grigoriu BD, Depontieu F, Scherpereel A, Gourcerol D, Devos P, Ouatas T, Lafitte JJ, Copin MC, Tonnel AB, Lassalle P.

Clin Cancer Res. 2006 Aug 1;12(15):4575-82.

11.

Vascular endothelial growth factor (VEGF) expression and survival in human epithelial ovarian carcinomas.

Hartenbach EM, Olson TA, Goswitz JJ, Mohanraj D, Twiggs LB, Carson LF, Ramakrishnan S.

Cancer Lett. 1997 Dec 23;121(2):169-75.

PMID:
9570355
12.

Stomatin-like protein 2 is overexpressed in epithelial ovarian cancer and predicts poor patient survival.

Sun F, Ding W, He JH, Wang XJ, Ma ZB, Li YF.

BMC Cancer. 2015 Oct 20;15:746. doi: 10.1186/s12885-015-1723-x.

13.

Vascular endothelial growth factor expression in stage I non-small cell lung cancer correlates with neoangiogenesis and a poor prognosis.

Han H, Silverman JF, Santucci TS, Macherey RS, d'Amato TA, Tung MY, Weyant RJ, Landreneau RJ.

Ann Surg Oncol. 2001 Jan-Feb;8(1):72-9.

PMID:
11206229
14.

Overexpression of EFEMP1 correlates with tumor progression and poor prognosis in human ovarian carcinoma.

Chen J, Wei D, Zhao Y, Liu X, Zhang J.

PLoS One. 2013 Nov 13;8(11):e78783. doi: 10.1371/journal.pone.0078783. eCollection 2013.

15.
16.
17.

Association of expression of XIAP-associated factor 1 (XAF1) with clinicopathologic factors, overall survival, microvessel density and cisplatin-resistance in ovarian cancer.

Wang Y, Mao H, Hao Q, Wang Y, Yang Y, Shen L, Huang S, Liu P.

Regul Pept. 2012 Oct 10;178(1-3):36-42. doi: 10.1016/j.regpep.2012.06.005. Epub 2012 Jul 1.

PMID:
22759793
18.

Endocan is upregulated on tumor vessels in invasive bladder cancer where it mediates VEGF-A-induced angiogenesis.

Roudnicky F, Poyet C, Wild P, Krampitz S, Negrini F, Huggenberger R, Rogler A, Stöhr R, Hartmann A, Provenzano M, Otto VI, Detmar M.

Cancer Res. 2013 Feb 1;73(3):1097-106. doi: 10.1158/0008-5472.CAN-12-1855. Epub 2012 Dec 14.

19.

Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.

Kato H, Yoshikawa M, Miyazaki T, Nakajima M, Fukai Y, Masuda N, Fukuchi M, Manda R, Tsukada K, Kuwano H.

Anticancer Res. 2002 Nov-Dec;22(6C):3977-84.

PMID:
12553021
20.

Endocan is a VEGF-A and PI3K regulated gene with increased expression in human renal cancer.

Rennel E, Mellberg S, Dimberg A, Petersson L, Botling J, Ameur A, Westholm JO, Komorowski J, Lassalle P, Cross MJ, Gerwins P.

Exp Cell Res. 2007 Apr 15;313(7):1285-94. Epub 2007 Feb 6.

PMID:
17362927

Supplemental Content

Support Center